Provided by Tiger Trade Technology Pte. Ltd.

SINOMAB BIO-B

1.230
-0.040-3.15%
Volume:669.30K
Turnover:836.77K
Market Cap:1.71B
PE:-12.37
High:1.320
Open:1.305
Low:1.215
Close:1.270
52wk High:3.630
52wk Low:0.990
Shares:1.39B
HK Float Shares:1.39B
Volume Ratio:0.70
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.099
ROE:-29.96%
ROA:-9.63%
PB:2.89
PE(LYR):-12.37
PS:256.19

Loading ...

SinoMab Announces Second Postponement of Circular for Suzhou Property Disposal, New Deadline Set for 21 August 2026

Bulletin Express
·
Aug 10

Sinomab Bio-B Keeps Share Count Steady in July; Grants 18.03 Million New Options While Maintaining Full Public Float

Bulletin Express
·
Aug 06

Autoimmune Sector Surges as Sinomab Bio-B Capitalizes on Differentiation for Growth Opportunities

Stock News
·
Jul 28

SinoMab Delays Circular on Suzhou Property Disposal to 10 August 2026

Bulletin Express
·
Jul 27

SinoMab Grants 18.03 Million Share Options to Executive Director and Senior Employee

Bulletin Express
·
Jul 24

SINOMAB BIO-B Grants 18.026 Million Share Options

Stock News
·
Jul 24

Sinomab Bioscience Grants 18,026,040 Share Options at HK$ 1.2 Each

Reuters
·
Jul 24

Sinomab BioScience Reports Stable Share Capital in June; 11.09 Million Options Lapse

Bulletin Express
·
Jul 07

Sinomab Bioscience - Announces Major Deal for Disposal of Suzhou Property and Facility for Rmb280 Mln

THOMSON REUTERS
·
Jul 06

Sinomab Bioscience to Sell Suzhou Property, Facility for RMB 280 Million

Reuters
·
Jul 06

SinoMab BioScience Adds Chief Operating Officer Fang Liang to Board as Executive Director

Bulletin Express
·
Jul 03

SINOMAB BIO-B Appoints Liang Fang as Executive Director

Stock News
·
Jul 03

Sinomab Bioscience Files Board, Board Committee and Management Disclosure List

Reuters
·
Jul 03

Sinomab Bioscience Appoints COO Fang Liang as Executive Director

Reuters
·
Jul 03

Sinomab Bioscience - Appoints Fang Liang as Executive Director Effective 3 July 2026

THOMSON REUTERS
·
Jul 03

SINOMAB BIO-B Appoints Xue Lei as Non-Executive Director

Stock News
·
Jun 12

SinoMab BioScience: AGM Resolutions Secure 100% Support; Lei Xue Named Non-Executive Director

Bulletin Express
·
Jun 12

Hong Kong Stock Movement | SINOMAB BIO-B Surges Over 25% in Late Trading on Robust Pipeline and High BD Potential

Stock News
·
Jun 11

Sinomab Bio-B Maintains 1.39 Billion Issued Shares and Public Float Compliance in May 2026 Return

Bulletin Express
·
Jun 04

SinoMab Presents Preclinical Study Data of Vitiligo, Alopecia Drug at Dermatology Conference

MT Newswires Live
·
May 14